問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of General Internal Medicine

Division of Infectious Disease

更新時間:2023-09-19

羅景霳
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2023-05-01 - 2024-04-29

Phase II

Completed
A Phase Ⅱ,Double-blind,Randomized,Controlled Study to Evaluate the Safety and Efficacy of Silmitasertib(CX-4945) in Hospitalized Adults with COVID-19
  • Condition/Disease

    Community-acquired Pneumonia 、SARS-CoV-2 -Associated Pneumonia 、Influenza With Pneumonia

  • Test Drug

    CX-4945

Participate Sites
1Sites

Recruiting1Sites

2021-03-01 - 2028-03-31

Phase III

Completed
A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in HIV-1 Infected Treatment-Naïve Participants
  • Condition/Disease

    HIV-1 Infection

  • Test Drug

    MK-8591A [Doravirine (MK-1439) + Islatravir (MK-8591)]BiktarvyR

Participate Sites
3Sites

Not yet recruiting2Sites

Recruiting1Sites